← All protocols
Grade BRUOverifiedBioGate · GREEN

Dermal & Follicular Renewal

Photoaged skin, scalp follicle restoration in androgenic-alopecia early stage

Protocol card

Eight audiences, one source of truth.

For clinicians

Dose & cycle

GHK-Cu 1% topical bid + microneedling 1.5 mm weekly

Cycle
Continuous topical
Duration
16 weeks, photographic + trichoscopy at week 0 / 8 / 16
For patients

Monitoring endpoints

  • modified Hamilton-Norwood
  • trichoscopy follicular density
  • VISIA wrinkle score
Contraindications
  • copper allergy
  • active dermatitis at site
Jurisdiction gates
US
Cosmetic, non-prescription
EU
Cosmetic regulation 1223/2009
UK
Cosmetic
AU
Cosmetic
Constituent peptides

Provenance, attestations, and structures.

GHK-CuverifiedBioGate · GREEN
Structural preview · ESMFold-2 mockdeterministic per sequence
GHK

Tripeptide-copper complex; modulates gene expression in dermal fibroblasts and downregulates TGF-β scarring pathways.

IP economics

Cohort outcomes feed the royalty cascade.

Every revealed OEA from this protocol's cohorts updates the upstream IPNFT's outcome posterior. Holders receive pro-rata royalties from licensing, lab-fee escrow, and approved CRO contracts. Peptide MD does not custody the IPNFT; it indexes it through the Molecule registry.

IPNFT · Molecule IPNFT V2Solana
GHK-Cu
bb9aee…94c09a
Royalty cascade
8.07%
Holders
323
Royalty cascade routes lab fees, licensing, and OEA-attested cohort revenues back to holders, the cohort treasury, and the originating researchers in a 60 / 25 / 15 split.
Supply provenance

COA-backed batches in the index.

BatchSupplierPurity (HPLC)Endotoxin (EU/mg)ManufacturedHash
HP-GHK-2026-0228-BHelix Pharma EU
Netherlands (GMP Annex 1)
98.9%0.182026-02-28
Citations

Every claim, traceable.

Grade A2018 · Int J Mol Sci

The Effect of the Human Peptide GHK on Gene Expression Relevant to Skin

Pickart L, Margolina A.

PMID 26371021